What 4 Analyst Ratings Have To Say About First Wave BioPharma
What 4 Analyst Ratings Have To Say About First Wave BioPharma
First Wave BioPharma (NASDAQ:FWBI) has observed the following analyst ratings within the last quarter:
First Wave BioPharma（纳斯达克股票代码：FWBI）在上个季度观察到以下分析师评级：
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 4 | 0 | 0 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 1 | 0 | 0 | 0 | 0 |
| 2M Ago | 1 | 0 | 0 | 0 | 0 |
| 3M Ago | 1 | 0 | 0 | 0 | 0 |
| 看涨 | 有点看涨 | 冷漠 | 有点看跌 | 看跌 | |
|---|---|---|---|---|---|
| 总收视率 | 4 | 0 | 0 | 0 | 0 |
| 最后 30 天 | 1 | 0 | 0 | 0 | 0 |
| 1 月前 | 1 | 0 | 0 | 0 | 0 |
| 2 万之前 | 1 | 0 | 0 | 0 | 0 |
| 3 万之前 | 1 | 0 | 0 | 0 | 0 |
In the last 3 months, 4 analysts have offered 12-month price targets for First Wave BioPharma. The company has an average price target of $12.0 with a high of $14.00 and a low of $10.00.
在过去的3个月中，有4位分析师为First Wave BioPharma提供了12个月的目标股价。该公司的平均目标价为12.0美元，最高为14.00美元，低点为10.00美元。
Below is a summary of how these 4 analysts rated First Wave BioPharma over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the more negative analysts are on the stock
以下是这四位分析师在过去3个月中对First Wave BioPharma的评级摘要。看涨评级的数量越多，分析师对该股票的正面评价就越多，看跌评级的数量越多，分析师对该股的负面评价就越多
This current average represents a 25.0% decrease from the previous average price target of $16.00.
目前的平均价格比之前的平均目标价16.00美元下降了25.0％。
Stay up to date on First Wave BioPharma analyst ratings.
随时了解第一波生物制药分析师评级的最新情况。
If you are interested in following small-cap stock news and performance you can start by tracking it here.
如果你有兴趣关注小盘股的新闻和表现，可以先在这里追踪。
Analyst Ratings: What Are They?
分析师评级：它们是什么？
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
评级来自分析师或银行和金融系统内的专家，他们对特定股票或特定行业进行报告（通常每只股票每季度报告一次）。分析师通常从公司电话会议和会议、财务报表以及与重要内部人士的对话中获取信息，以做出决策。
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
一些分析师还对收益、收入和增长估计等有用指标提供了预测，以进一步指导如何处理某些股票。重要的是要记住，虽然股票和行业分析师是专家，但他们也是人类，只能向交易者预测自己的信念。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成，并由编辑审阅。